Bevatres 5 mg/ 160 mg/ 25 mg Filmdragerad tablett

देश: स्वीडन

भाषा: स्वीडिश

स्रोत: Läkemedelsverket (Medical Products Agency)

इसे खरीदें

सक्रिय संघटक:

amlodipinbesilat; hydroklortiazid; valsartan

थमां उपलब्ध:

Teva B.V.

ए.टी.सी कोड:

C09DX01

INN (इंटरनेशनल नाम):

amlodipinbesilat; hydrochlorothiazide; valsartan

डोज़:

5 mg/ 160 mg/ 25 mg

फार्मास्यूटिकल फॉर्म:

Filmdragerad tablett

रचना:

laktosmonohydrat Hjälpämne; valsartan 160 mg Aktiv substans; hydroklortiazid 25 mg Aktiv substans; amlodipinbesilat 6,93 mg Aktiv substans

प्रिस्क्रिप्शन प्रकार:

Receptbelagt

उत्पाद समीक्षा:

Förpacknings: Blister, 14 tabletter; Blister, 28 tabletter; Blister, 30 tabletter; Blister, 56 tabletter; Blister, 90 tabletter; Blister, 98 tabletter; Burk, 100 tabletter

प्राधिकरण का दर्जा:

Avregistrerad

प्राधिकरण की तारीख:

2020-04-15

उत्पाद विशेषताएं

                                1
SUMMARY OF PRODUCT CHARACTERISTICS
2
1.
NAME OF THE MEDICINAL PRODUCT
Bevatres10 mg/160 mg/12.5 mg film-coated tablets
Bevatres5 mg/160 mg/25 mg film-coated tablets
Bevatres 10 mg/160 mg/25 mg film-coated tablets
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
[Product name] 10 mg/160 mg/12.5 mg film-coated tablets
Each film-coated tablet contains amlodipine besilate equivalent to 10
mg amlodipine, 160 mg of
valsartan, and 12.5 mg of hydrochlorothiazide.
[Product name] 5 mg/160 mg/25 mg film-coated tablets
Each film-coated tablet containsamlodipine besilate equivalent to 5 mg
amlodipine, 160 mg of
valsartan, and 25 mg of hydrochlorothiazide.
[Product name] 10 mg/160 mg/25 mg film-coated tablets
Each film-coated tablet containsamlodipine besilate equivalent to 10
mg amlodipine, 160 mg of
valsartan, and 25 mg of hydrochlorothiazide.
Excipient(s) with known effect
[Product name] 10 mg/160 mg/12.5 mg film-coated tablets
Each tablet contains 5 mg of lactose.
[Product name] 5 mg/160 mg/25 mg film-coated tablets
Each tablet contains 5 mg of lactose.
[Product name] 10 mg/160 mg/25 mg film-coated tablets
Each tablet contains 5 mg of lactose.
For the full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Film-coated tablet (tablet)
[Product name] 10 mg/160 mg/12.5 mg film-coated tablets
Oval, light yellow, 14.5 mm x 7.5 mm film-coated tablets with bevelled
edges, with debossing VIL on
one side of the tablet.
[Product name] 5 mg/160 mg/25 mg film-coated tablets
Oval, yellow, 14.5 mm x 7.5 mm film-coated tablets with bevelled
edges, with debossing VIH on one
side of the tablet
[Product name] 10 mg/160 mg/25 mg film-coated tablets
Oval, dark yellow, 14.5 mm x 7.5 mm film-coated tablets with bevelled
edges, with debossing VIT on
one side of the tablet.
4.
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
3
Treatment of essential hypertension as substitution therapy in adult
patients whose blood pressure is
adequately controlled on the combination of amlodipine, valsartan and
hydrochlorothiazide (HCT),
taken either as th
                                
                                पूरा दस्तावेज़ पढ़ें
                                
                            

अन्य भाषाओं में दस्तावेज़

सूचना पत्रक सूचना पत्रक अंग्रेज़ी 21-01-2022
उत्पाद विशेषताएं उत्पाद विशेषताएं अंग्रेज़ी 31-08-2020